Answers are grounded in this paper and cite their sources.
Assesses HHV-6 DNAemia effects in transplant patients, suggesting links to immune responses and complications.
The clinical significance of human herpesvirus-6 (HHV-6) after allogeneic hematopoietic cell transplantation (HCT) is debated. We prospectively collected weekly whole-blood HHV-6 in 217 PTCy-based HCT recipients. One-hundred forty-nine (69%) patients had at least one detection, at a median of 21 days post-HCT, and 63 (29%) spiked ≥4*log10 copies/mL (high-level HHV-6 DNAemia) at median day +27. Hematologic malignancy, myeloablative conditioning, HLA-partially-mismatched donor, marrow graft, PTCy dose, and sirolimus use were associated on univariate analysis with high-level HHV-6 DNAemia. All spikes precipitously declined spontaneously, but after initial decline, 27% persisted at ≥3*log10 copies/mL for >1 month. Those with HHV-6 spikes had lower day +28 CD4+ T-cell counts. During initial spikes, there was a strong correlation between plasma and whole blood HHV-6 DNAemia (Spearman's ρ=0.85, p<0.0001). By contrast, in patients with HHV-6 persisting >1 month, HHV-6 was predominantly found within CD4+ T-cells, but not in plasma. Only one patient developed HHV-6-associated encephalitis, but high-level HHV-6 DNAemia was associated with increased rates of otherwise unexplained fever (35% vs 21% in patients without high-HHV-6 DNAemia, p=0.036), rash (27% vs 12%, p=0.009), transaminitis (52% vs 27%, p=0.001), and gastrointestinal symptoms (23% vs 7%, p=0.0036) as well as increased risk of acute (36% vs 18%, p=0.007) and moderate-to-severe chronic (22% vs 8%, p=0.01) graft-versus-host disease. HHV-6 detection occurs frequently in PTCy-recipients but infrequently leads to classic HHV-6-related disease (encephalitis), although it associates with various self-limited clinical symptoms, may play a role in shaping immune reconstitution, and may serve as a marker for increased GVHD risk. (NCT04959175, NCT05436418, NCT02579967, NCT03983850, NCT03922724, NCT03663933)
No takes yet. Share an insight, caveat, or question.
Xue et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: